(NASDAQ: PRCT) Procept Biorobotics's forecast annual revenue growth rate of 34.16% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.43%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Procept Biorobotics's revenue in 2025 is $224,498,000.On average, 6 Wall Street analysts forecast PRCT's revenue for 2025 to be $17,819,750,353, with the lowest PRCT revenue forecast at $17,685,608,994, and the highest PRCT revenue forecast at $18,348,586,352. On average, 6 Wall Street analysts forecast PRCT's revenue for 2026 to be $23,434,720,157, with the lowest PRCT revenue forecast at $22,744,278,630, and the highest PRCT revenue forecast at $24,615,898,685.
In 2027, PRCT is forecast to generate $29,878,877,616 in revenue, with the lowest revenue forecast at $27,250,375,770 and the highest revenue forecast at $32,332,069,260.